Overview

TAK-935 Multiple Rising Dose Study in Healthy Participants

Status:
Completed

Trial end date:
2016-04-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to assess the safety, tolerability and pharmacokinetics (PK) of multiple rising doses of TAK-935 in healthy participants.

Phase:

Phase 1

Details

Lead Sponsor:

Takeda

Treatments:

Pharmaceutical Solutions